Table 3.

Visual Acuity Outcomes for Culture-Positive Endophthalmitis After Intravitreal Anti–Vascular Endothelial Group Factor Injection in the Face Mask Group vs No Talking Group

	Face Mask Culture-Positive Group (N = 5)	“No Talking” Culture-Positive Group (N = 47)	P Value
Mean logMAR VA at causative injection	0.24	0.58	.093
Mean logMAR VA at endophthalmitis presentation	1.58	2.29	.036∗
Average lines of Snellen VA lost from baseline at endophthalmitis presentation	13.4 lines	17.1 lines	.031∗
Mean logMAR VA at 6 months	0.87	1.53	.157
Average lines of Snellen VA lost from baseline at 6 months	6.3 lines	9.5 lines	.479
Three lines or more of Snellen VA lost from baseline at 6 months, N (%)	2 (40%)	27 (66%)	.258
VA of CF or worse at 6 months, N (%)	0 (0%)	11 (27%)	.184
Mean logMAR VA at last follow-up	1.22	1.65	.383
Average lines of Snellen VA lost from baseline at last follow-up	9.8 lines	10.8 lines	.834
Three lines or more of Snellen VA lost from baseline at last follow-up, n (%)	4 (80%)	30 (65%)	.505
VA of CF or worse at last follow-up, n (%)	1 (20%)	17 (37%)	.451

CF = count fingers; VA = visual acuity.

^*P < 0.05.